AstraZeneca virus vaccine shows promise in trial
UK company expects to begin Japan tests in August
Some of the many vaccines being rushed through development are starting to show promise.
LONDON/TOKYO -- A coronavirus vaccine being developed by British pharmaceutical AstraZeneca and Oxford University showed a robust immune response in the early phases of its trial.
The company is expected to begin trials in Japan in August as the world waits for a vaccine to stop the pandemic.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapterFind out more
Free access for everyone - Sep. 30